Hillary campaign swats at Iran charge in ‘Clinton Cash’
A new book claims she watered down sanctions to please a company that paid her husband for a speech.
Blog
American, Italian hostages inadvertently killed in U.S. operation: Obama
By Will Dunham and Julia Edwards WASHINGTON (Reuters) – An American and an Italian who had been held hostage for several years by al Qaeda in the border region of Pakistan and Afghanistan were inadvertently killed in a U.S. counterterrorism operation in January, President Barack Obama said on Thursday. On behalf of the United States government, I offer our deepest apologies to the families,” Obama said in an appearance at
Exclusive: Clinton charities will refile tax returns, audit for other errors
By Jonathan Allen NEW YORK (Reuters) – Hillary Clinton’s family’s charities are refiling at least five annual tax returns after a Reuters review found errors in how they reported donations from governments, and said they may audit other Clinton Foundation returns in case of other errors. The foundation and its list of donors have been under intense scrutiny in recent weeks. Republican critics say the foundation makes Clinton, who is
High costs hinder outfitting of U.S. cops with body cameras
By Julia Edwards and Anjali Athavaley WASHINGTON/NEW YORK (Reuters) – A recent series of widely publicized police shootings of unarmed civilians has heightened interest across the United States in outfitting patrol officers with body cameras. More than a half-dozen companies are competing to supply the nation’s nearly 700,000 sworn officers with body cameras, which can cost between $350 and $700 apiece.
Chile volcano erupts for first time in decades
A volcano in Chile that had been inactive for over 50 years suddenly erupted twice in the space of hours, blasting huge clouds of ash into the air and forcing the evacuation of around 5,000 people. There were no immediate reports of injuries after the eruptions from the Calbuco volcano in southern Chile late Wednesday and again before sunrise on Thursday. A state of emergency was declared after the first
Justice for Freddie Gray
Where does the investigation stand in the death of Freddie Gray, a 25-year-old Baltimore man who apparently suffered grievous injuries to his spine while in police custody? Billy Murphy, Jr., an attorney for Freddie Gray’s family, speaks to Yahoo News and Finance Anchor Bianna Golodryga and offers his views on where the case stands, and what needs to be done to ensure justice for Mr. Gray and his family.
Tsarnaev middle finger photo formally entered into evidence
Prosecutors formally enter into evidence a video still of the now-convicted Boston Marathon bomber giving a courthouse security camera the middle finger.
Scientists urge moratorium after Chinese 'edit' human embryos
Global scientists on Thursday renewed calls to halt controversial research to genetically edit human embryos after a Chinese team published details of a stunted but breakthrough attempt in this new frontier in science. First reported by Nature News on Wednesday, the paper by Junjiu Huang, a gene-function researcher at Sun Yat-sen University in Guangzhou, and colleagues appears in a little known online journal called Protein and Cell. Researchers “attempted to
FDA grants priority review to Boehringer's drug to reverse blood thinning
(Reuters) – Boehringer Ingelheim Pharmaceuticals Inc said its drug to reverse blood thinning was granted a priority review status by the U.S. Food and Drug Administration, accelerating the regulatory process by four months. The drug, idarucizumab is specifically being tested to reverse the blood thinning effects of Pradaxa, the privately held company said in a statement on Thursday.
AstraZeneca, Juno latest to collaborate on immuno-oncology drugs
(Reuters) – A unit of AstraZeneca Plc has teamed up with Juno Therapeutics Inc to develop combination treatments that use the body’s immune system to kill cancer cells. The partnership between AstraZeneca’s research and development arm MedImmune and Juno is the latest collaboration between companies intent on developing a new class of drugs known as immuno-oncology therapies, considered a breakthrough in cancer treatment. The past year has seen tie-ups between